Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective
- PMID: 23855464
- DOI: 10.1111/nyas.12150
Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective
Abstract
Primary prevention of cardiovascular disease (CVD) aims to avoid a first event in subjects that are at risk but have not yet been diagnosed with heart disease. Secondary prevention of CVD aims to avoid new events in patients with established heart disease. Both approaches involve clinical intervention and implementation of healthy lifestyles. The grape and wine polyphenol resveratrol (3,5,4'-trihydroxy-trans-stilbene) has shown cardioprotective benefits in humans. Most of these approaches deal with rather high doses and short follow-ups, and do not address the issue of long-term resveratrol consumption safety, especially in medicated individuals. Here, we review the trials conducted with resveratrol in patients at risk for or with established CVD, focusing on the two longest human clinical trials reported so far (1-year follow-up). We also discuss the expectations for resveratrol from a dietary and clinical perspective in relation to CVD. However, statistically significant changes in CVD-risk markers do not necessarily equal clinical significance in the daily care of patients.
Keywords: cardiovascular; clinical trial; grape; nutraceutical; polyphenol; resveratrol.
© 2013 New York Academy of Sciences.
Similar articles
-
One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.Am J Cardiol. 2012 Aug 1;110(3):356-63. doi: 10.1016/j.amjcard.2012.03.030. Epub 2012 Apr 19. Am J Cardiol. 2012. PMID: 22520621 Clinical Trial.
-
The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.Ann N Y Acad Sci. 2013 Jul;1290:130-5. doi: 10.1111/nyas.12216. Ann N Y Acad Sci. 2013. PMID: 23855475 Review.
-
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.Mol Nutr Food Res. 2012 May;56(5):810-21. doi: 10.1002/mnfr.201100673. Mol Nutr Food Res. 2012. PMID: 22648627 Clinical Trial.
-
Interventions for cardiovascular disease prevention.Cardiol Clin. 2011 Feb;29(1):15-34. doi: 10.1016/j.ccl.2010.10.005. Cardiol Clin. 2011. PMID: 21257098 Review.
-
Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance' by Calabrese et al.Hum Exp Toxicol. 2010 Dec;29(12):1016-7. doi: 10.1177/0960327110383626. Hum Exp Toxicol. 2010. PMID: 21115560
Cited by
-
OTC Antioxidant Products for the Treatment of Cardiovascular and other Disorders: Popular Myth or Fact?J Pharmacovigil. 2015 Apr;3(2):e136. doi: 10.4172/2329-6887.1000e136. J Pharmacovigil. 2015. PMID: 26052537 Free PMC article. No abstract available.
-
Resveratrol supplementation rescues pool of growing follicles and ovarian stroma from Cisplatin-induced toxicity on the ovary in Sprague-Dawley rats: An experimental study.Int J Reprod Biomed. 2018 Jan;16(1):19-30. Int J Reprod Biomed. 2018. PMID: 29675484 Free PMC article.
-
Resveratrol: a supplementation for men or for mice?J Transl Med. 2014 Jun 3;12:158. doi: 10.1186/1479-5876-12-158. J Transl Med. 2014. PMID: 24893845 Free PMC article.
-
Resveratrol supplementation at old age reverts changes associated with aging in inflammatory, oxidative and apoptotic markers in rat heart.Eur J Nutr. 2021 Aug;60(5):2683-2693. doi: 10.1007/s00394-020-02457-0. Epub 2021 Jan 2. Eur J Nutr. 2021. PMID: 33386891
-
Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model.Exp Ther Med. 2017 May;13(5):2071-2078. doi: 10.3892/etm.2017.4180. Epub 2017 Mar 2. Exp Ther Med. 2017. PMID: 28565810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources